1-20 of 31
Borhane Slama
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased Thromboinflammation Is Associated with High Thrombotic Risk in Patients with Myeloproliferative Neoplasms: A Multicentric Study of 394 Cases By the French Intergroup of Myeloproliferative Neoplasms (FIM)

Alexandre Guy, Olivier Mansier, Alexandre Catherineau, Geoffrey Garcia, Sylvie Labrouche-Colomer, Valentin Landrieu, Marie-Lise Bats, Francoise Boyer, Jean-Christophe Ianotto, Lydia Roy, Suzanne Tavitian, Borhane Slama, Stephane Girault, Gabriel Etienne, Anne Parry, Arnaud Saint-Lezer, Guillaume Denis, Clemence Mediavilla, Jean-Francois Viallard, Laurence Legros, Dana Ranta, Mathieu Wemeau, Franck E. Nicolini, Francois Lifermann, Nathalie Cambier, Luc Darnige, Francois Girodon, Juliette Soret-Dulphy, Emilie Cayssials, Fabienne Vacheret, Léa Sureau, Damien Luque-Paz, Valérie Ugo, Jean-Jacques Kiladjian, Rodolphe Thiébaut, Chloe James
Journal: Blood
Blood (2024) 144 (Supplement 1): 3133.
https://doi.org/10.1182/blood-2024-194702
Published: 2024
Journal Articles

Valemetostat Monotherapy in Patients with Relapsed or Refractory Large B-Cell Lymphoma: Primary Results of the Phase 2 Valym Study from the Lysa

Emmanuel Bachy, Bernard Drenou, Fabrice Jardin, Keiko Nakajima, Katell Le Du, Gandhi Damaj, Fontanet Bijou, Borhane Slama, Gian Matteo Pica, Gaetan Vanstraelen, Charles Herbaux, Roch Houot, Francois Lemonnier, Julie Gay, Pierre Sujobert, Marguerite Fournier, Marlene Ochmann, Romain Guieze, Jorge Zeron, Alexandra Traverse-Glehen, Jean Marc Schiano De Colella, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 4479.
https://doi.org/10.1182/blood-2024-193960
Published: 2024
Journal Articles

High-Risk Multiple Myeloma in Benefit (IFM 2020-05) Phase 3 Randomized Study of Isatuximab (Isa) Plus Lenalidomide and Dexamethasone (Rd) with Bortezomib Versus Isard in Patients with Newly Diagnosed Transplant Ineligible Multiple Myeloma (NDMM TI)

Jill Corre, Jérôme Lambert, Arthur Bobin, Salomon Manier, Aurore Perrot, Lionel Karlin, Murielle Roussel, Noemie Bigot, Omar Benbrahim, Olivier Thierry Allangba, Philippe Rey, Veronique Dorvaux, Marguerite Vignon, Virginie Roland, Reda Garidi, Jean-Noel Bastie, Marie-Lorraine Chrétien, Sophie Godet, Lydia Montes, Brieuc Cherel, Thomas Chalopin, Borhane Slama, Kamel Laribi, Claire Dingremont, Christophe Roul, Valentine Richez, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Jean Pierre Marolleau, Pascal Godmer, Laurent Frenzel, Ronan Le Calloch, Emilie Chalayer, Helene Gardeney, Margaret Macro, Bruno Royer, Olivier Decaux, Bertrand Arnulf, Karim Belhadj Merzoug, Cyrille Touzeau, Mohamad Mohty, Aurelie Gontier, Amine Kasmi, Philippe Moreau, Thierry Facon, Herve Avet Loiseau, Cyrille Hulin, Xavier Leleu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4756.
https://doi.org/10.1182/blood-2024-210345
Published: 2024
Journal Articles

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor

CME Clinical Trials & Observations
Anaïs Schavgoulidze, Alexis Talbot, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Salomon Manier, Laure Buisson, Sabrina Mahéo, Laura Do Souto Ferreira, Luka Pavageau, Cyrille Hulin, Jean-Pierre Marolleau, Laurent Voillat, Karim Belhadj, Marion Divoux, Borhane Slama, Sabine Brechignac, Margaret Macro, Anne-Marie Stoppa, Laurence Sanhes, Frédérique Orsini-Piocelle, Jean Fontan, Marie-Lorraine Chretien, Hélène Demarquette, Mohamad Mohty, Hervé Avet-Loiseau, Jill Corre
Journal: Blood
Blood (2023) 141 (11): 1308–1315.
https://doi.org/10.1182/blood.2022017863
Published: 2023
Includes: Supplemental data
Journal Articles

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

Clinical Trials & Observations
Murielle Roussel, Valérie Lauwers-Cances, Margaret Macro, Xavier Leleu, Bruno Royer, Cyrille Hulin, Lionel Karlin, Aurore Perrot, Cyrille Touzeau, Marie-Lorraine Chrétien, Sophie Rigaudeau, Mamoun Dib, Emmanuelle Nicolas-Virelizier, Martine Escoffre-Barbe, Karim Belhadj, Clara Mariette, Anne-Marie Stoppa, Carla Araujo, Chantal Doyen, Jean Fontan, Brigitte Kolb, Laurent Garderet, Sabine Brechignac, Jean-Valère Malfuson, Arnaud Jaccard, Pascal Lenain, Cécile Borel, Benjamin Hebraud, Omar Benbrahim, Véronique Dorvaux, Salomon Manier, Karine Augeul-Meunier, Marie-Christiane Vekemans, Edouard Randriamalala, Driss Chaoui, Jo Caers, Carine Chaleteix, Lofti Benboubker, Laure Vincent, Sylvie Glaisner, Patricia Zunic, Borhane Slama, Jean-Richard Eveillard, Catherine Humbrecht-Kraut, Véronique Morel, Philippe Mineur, Jean-Claude Eisenmann, Hélène Demarquette, Valentine Richez, Marguerite Vignon, Denis Caillot, Thierry Facon, Philippe Moreau, Anne-Laurène Colin, Pascale Olivier, Soraya Wuilleme, Hervé Avet-Loiseau, Jill Corre, Michel Attal
Journal: Blood
Blood (2022) 139 (18): 2747–2757.
https://doi.org/10.1182/blood.2021014635
Published: 2022
Includes: Supplemental data
Journal Articles

Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features

Brief Report
Titouan Cazaubiel, Xavier Leleu, Aurore Perrot, Salomon Manier, Laure Buisson, Sabrina Maheo, Laura Do Souto Ferreira, Romain Lannes, Luka Pavageau, Cyrille Hulin, Jean-Pierre Marolleau, Laurent Voillat, Karim Belhadj, Marion Divoux, Borhane Slama, Sabine Brechignac, Margaret Macro, Anne-Marie Stoppa, Laurence Sanhes, Frédérique Orsini-Piocelle, Jean Fontan, Marie-Lorraine Chretien, Hélène Demarquette, Mohamad Mohty, Anais Schavgoulidze, Herve Avet-Loiseau, Jill Corre
Journal: Blood
Blood (2022) 139 (17): 2666–2672.
https://doi.org/10.1182/blood.2021014968
Published: 2022
Includes: Supplemental data
Journal Articles

Real-World Evidence of the Use of Carfilzomib Among Multiple Myeloma Patients with at Least One Prior Therapy across 10 European Countries and Israel

Evangelos Terpos, MDPhD, Borhane Slama, MD, Renato Zambello, Sorina Nicoleta Badelita, MD, Eirini Katodritou, MD, Jo Caers, MD PhD, Thomas Kühr, MD, Florence Suzan, MD, Abeera Mohammad, MSc, Sally Wetten, MSc, Xavier Leleu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-134475
Published: 2020
Journal Articles

Real-World Evidence of the Use of Approved Carfilzomib Regimens in Patients Previously Exposed or Refractory to Lenalidomide: Updated Results from a Prospective Observational Study

Xavier Leleu, MD, Borhane Slama, MD, Renato Zambello, Sorina Nicoleta Badelita, MD, Eirini Katodritou, MD, Jo Caers, MD PhD, Thomas Kühr, MD, Florence Suzan, MD, Abeera Mohammad, MSc, Sally Wetten, MSc, Evangelos Terpos, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-134476
Published: 2020
Journal Articles

Biomarkers of Response to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndrome (MDS) and Thrombocytopenia - Results of the Europe Trial By the Emsco Network

Uwe Platzbecker, MD, Anne Sophie Kubasch, MD, Aristoteles Giagounidis, MD, Georgia Metzgeroth, Anna Jonasova, MD PhD, Regina Herbst, MD, Jose Miguel Torregrosa Diaz, Benoit De Renzis, MD, Katharina Götze, Marie-Luise Huetter-Kroenke, MD, Marie-Pierre Gourin, Borhane Slama, MD, Sophie Dimicoli-Salazar, MD, Pascale Cony-Makhoul, MD, Kamel Laribi, MD, Sophie Park, MD PhD, Katja Jersemann, Oliver Tiebel, MD, Katja Sockel, MD, Silke Gloaguen, MSc, Anna Mies, Fatiha Chermat, Christian Thiede, MD, Rosa Sapena, Richard F. Schlenk, MD, Pierre Fenaux, MD PhD, Lionel Ades, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2998.
https://doi.org/10.1182/blood-2019-129047
Published: 2019
Journal Articles

Clinical Spectrum, Long-Term Outcomes and Predictors of Relapse after Imatinib Discontinuation in FIP1L1-Pdgfra-Associated Chronic Eosinophilic Leukemia: Data from 150 Patients

Julien Rohmer, MD, Matthieu Groh, MD, Julie Trichereau, Kewin Panel, Claude Preudhomme, PharmD, PhD, Fanny Legrand, PhD PharmD, Felix Ackermann, MD, Amélie Couteau-Chardon, MD, Mikael Ebbo, MD PhD, Olivier Fain, MD, Lionel Galicier, MD, Mohamed Hamidou, Mathilde Hunault, MD PhD, Etienne Lengline, MD, Catherine Mohr, MD, Franck E Nicolini, MD PhD, Jerome Rey, Louis Terriou, MD, Chafika Morati Hafsaoui, MD, Suzanne Tavitian, MD, Irene Machelart, Katayoun Jondeau, MD, Bertrand Arnulf, Jean-Christophe Ianotto, MD PhD, Jean-Marc Zini, Viviane Dubruille, MD, Francoise Huguet, MD, Borhane Slama, MD, Fabrice Jardin, Didier Adiko, Elise Toussaint, MD, Aurelien Guffroy, MD PhD, Faustine Lhomme, MD PhD, Nathalie Grardel, Cyrielle Gesquieres, Guillaume Lefèvre, MD PhD, Jean Emmanuel Kahn, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 840.
https://doi.org/10.1182/blood-2019-130009
Published: 2019
Journal Articles

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data

Fabien Le Bras, Philippe Gaulard, MD PhD, Marc Andre, MD, Corinne Haioun, MD PhD, Romain Bosc, MD PhD, Camille Laurent, MD PhD, Lionel Tortelano, PD, Thua-Ha Dao, MD, Emmanuel Itti, MD PhD, Caroline Malhaire, MD, Schiano de Colella Jean Marc, MD, Marie Bannier, MD, Emmanuel Bachy, MD PhD, Borhane Slama, MD, Luc Mathieu Fornecker, MD PhD, Lucie Oberic, MD, Alexandra Traverse-Glehen, MD PhD, Manon Croix, Julie Bonnefoy, Patrick Fogarty, Feriel Bouabbas, Nadia Amara, Virginie Fataccioli, PhD, Romain Ricci, Tania Cassubie-Mercier, Youlia Kirova, MD, Fabien Reyal, Herve Tilly, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Luc Xerri, MD PhD, Christophe Bonnet, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4021.
https://doi.org/10.1182/blood-2019-129123
Published: 2019
Journal Articles

Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) MDS Patients with Del(5q) — Preliminary Blinded Analysis of the European Sintra-REV Trial

Félix López Cadenas, MD, Eva Lumbreras, Blanca Xicoy, Joaquin Sanchez-Garcia, MD PhD, Pierre Fenaux, MD PhD, Rosa Coll, Borhane Slama, MD, Jose Angel Hernandez-Rivas, MD, Sylvain Thepot, MD, Teresa Bernal, MD, Beatriz Arrizabalaga, MD PhD, Agnès Guerci, Guillermo Sanz, Joan Bargay, MD PhD, Maria Luz Amigo, Raquel de Paz, Aristoteles Giagounidis, Uwe Platzbecker, Benet Nomdedeu, Eric Jourdan, MD, Katharina S. Götze, MD, Ali Arar, Jesús María Hernández-Rivas, MD PhD, Consuelo Del Cañizo, MDPhD, María Díez-Campelo
Journal: Blood
Blood (2018) 132 (Supplement 1): 468.
https://doi.org/10.1182/blood-2018-99-119430
Published: 2018
Journal Articles

Impact of Treatment with Iron Chelation Therapy in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Marlijn Hoeks, MD, Ge Yu, MSc., Saskia Langemeijer, MD PhD, Simon Crouch, MSc, PhD, Louise De Swart, MD, Pierre Fenaux, MD PhD, Argiris Symeonidis, MD PhD, Jaroslav Cermak, MD PhD, Eva Hellstrom-Lindberg, MD PhD, Guillermo Sanz, MD, Reinhard Stauder, MD, Mette skov-Holm, Moshe Mittelman, MD, Krzysztof Madry, MD PhD, Luca Malcovati, MD, Aurelia Tatic, MD, Antonio Medina de Almeida, MD PhD, Ulrich Germing, MD, Aleksandar Savic, MD PhD, Njetočka Gredelj-Šimec, MD, Dominic Culligan, MD, Raphael Itzykson, MD PhD, Agnes Guerci-Bresler, Borhane Slama, MD, Corine van Marrewijk, PhD, Jackie Droste, PhD, Marian van Kraaij, MD PhD, David T. Bowen, MD, T. M. M de Witte, MD PhD, Alex Smith, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 425.
https://doi.org/10.1182/blood.V130.Suppl_1.425.425
Published: 2017
Journal Articles

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Olivier Kosmider, Frederic Maloisel, Bernard Drenou, MD, Nicolas Chapuis, PharmD, PhD, Anne Sophie Alary, Alice Rousseau, Cecile Bouilloux, Sarah Ducamp, PhD, Frederique Verdier, Thibaud Lefebvre, Zoubida Karim, Marie-Christine Jacob, Agathe Debliquis, Agnes Charpentier, Pierre Fenaux, MD PhD, Emmanuel Gyan, MDPhD, Bruno Anglaret, Cecile Leyronnas, Selim Corm, Borhane Slama, MD, Stephane Cheze, Kamel Laribi, Shanti Ame, MD, Christian Rose, MD, Florence Lachenal, Andrea Toma, MD PhD, Gian Matteo Pica, MD, Martin Carre, Frederic Garban, Brigitte Pegourie, MD, Jean-Yves Cahn, Mathieu Meunier, MD, Orianne Wagner Ballon, Olivier Herault, MDPhD, Francois Dreyfus, Valerie Bardet, Michaela Fontenay, MD PhD, Sophie Park, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1705.
https://doi.org/10.1182/blood.V130.Suppl_1.1705.1705
Published: 2017
Journal Articles

A Phase 3 Randomized Placebo (PBO)-Controlled Double-Blind Trial of Darbepoetin Alfa in the Treatment of Anemia in Patients with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndromes (MDS)

Uwe Platzbecker, MD, Argiris Symeonidis, Esther N. Oliva, Jeroen S. Goede, Michel Delforge, Jiri Mayer, Borhane Slama, Sejal Badre, Eduard Gasal, Bhakti Mehta, Janet Franklin
Journal: Blood
Blood (2016) 128 (22): 2010.
https://doi.org/10.1182/blood.V128.22.2010.2010
Published: 2016
Journal Articles

VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial

Clinical Trials & Observations
Philippe Moreau, Cyrille Hulin, Margaret Macro, Denis Caillot, Carine Chaleteix, Murielle Roussel, Laurent Garderet, Bruno Royer, Sabine Brechignac, Mourad Tiab, Mathieu Puyade, Martine Escoffre, Anne-Marie Stoppa, Thierry Facon, Brigitte Pegourie, Driss Chaoui, Arnaud Jaccard, Borhane Slama, Gerald Marit, Karim Laribi, Pascal Godmer, Odile Luycx, Jean-Claude Eisenmann, Olivier Allangba, Mamoun Dib, Carla Araujo, Jean Fontan, Karim Belhadj, Marc Wetterwald, Véronique Dorvaux, Jean-Paul Fermand, Philippe Rodon, Brigitte Kolb, Sylvie Glaisner, Jean-Valere Malfuson, Pascal Lenain, Laetitia Biron, Lucie Planche, Helene Caillon, Herve Avet-Loiseau, Thomas Dejoie, Michel Attal
Journal: Blood
Blood (2016) 127 (21): 2569–2574.
https://doi.org/10.1182/blood-2016-01-693580
Published: 2016
Journal Articles

Bortezomib, Thalidomide and Dexamethasone (VTD) Is Superior to Bortezomib, Cyclophosphamide and Dexamethasone (VCD) Prior to Autologous Stem Cell Transplantation for Patients with De Novo Multiple Myeloma. Results of the Prospective IFM 2013-04 Trial

Philippe Moreau, Cyrille Hulin, Margaret MACRO, MD, Denis Caillot, Carine Chaleteix, Murielle Roussel, Laurent Garderet, MD, Bruno Royer, MD, Sabine Brechignac, MD, Mourad Tiab, MD, Mathieu Puyade, MD, Martine Escoffre, Anne-Marie Stoppa, MD, Thierry Facon, Brigitte Pégourie, Driss Chaoui, MD, Arnaud Jaccard, MD PhD, Borhane Slama, Gerald Marit, Kamel Laribi, Pascal Godmer, MD, Odile Luycx, Jean Claude Eisenmann, MD, Olivier Allangha, Sylvie Glaisner, Mamoun Dib, Carla Araujo, Jean Fontan, Karim Belhadj, MD, Marc Wetterwald, MD PhD, Veronique Dorvaux, Jean-Paul Fermand, Philippe Rodon, MD, Brigitte Kolb, Pascal Lenain, MD, Lucie Planche, Laetitia Biron, Helene Caillon, Herve Avet-Loiseau, Thomas Dejoie, Michel Attal
Journal: Blood
Blood (2015) 126 (23): 393.
https://doi.org/10.1182/blood.V126.23.393.393
Published: 2015
Journal Articles

Bing Neel Syndrome: The French Experience

Laurence Simon, Xavier Leleu, MD PhD, Jehan Dupuis, MD, Therese Aurran, MD, Lauris Gastaud, MD, Carole Soussain, MD, Beatrice Mahe, MD, Stephane Lepretre, MD, Borhane Slama, Guillaume Cartron, MD, Charlotte Bonnet, Olivier Gisserot, Camille Payet, Veronique Leblond, MD PhD, Luc Fornecker, MD
Journal: Blood
Blood (2014) 124 (21): 3068.
https://doi.org/10.1182/blood.V124.21.3068.3068
Published: 2014
Journal Articles

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

Clinical Trials & Observations
Mehdi Khellaf, Anaïs Charles-Nelson, Olivier Fain, Louis Terriou, Jean-François Viallard, Stéphane Cheze, Julie Graveleau, Borhane Slama, Sylvain Audia, Mikael Ebbo, Guillaume Le Guenno, Manuel Cliquennois, Gilles Salles, Caroline Bonmati, France Teillet, Lionel Galicier, Arnaud Hot, Olivier Lambotte, François Lefrère, Salimatou Sacko, Dieudonné Kilendo Kengue, Philippe Bierling, Françoise Roudot-Thoraval, Marc Michel, Bertrand Godeau
Journal: Blood
Blood (2014) 124 (22): 3228–3236.
https://doi.org/10.1182/blood-2014-06-582346
Published: 2014
Journal Articles

Validation Of The Revised International Prognostic Scoring System (IPSS-R) In 1000 Newly Diagnosed MDS Patients With Low- and Intermediate-1 Risk MDS In The European Leukemianet MDS (EUMDS) Registry

Louise de Swart, Alex Smith, Tom Johnston, Detlef Haase, MD, Jackie Droste, Pierre Fenaux, Argiris Symeonidis, MD, PhD, Guillermo Sanz, MD, PhD, Eva Hellström-Lindberg, Jaroslav Cermak, Ass. Prof., PhD, Ulrich Germing, MD, Reinhard Stauder, MD, MSc, Otilia Georgescu, Marius MacKenzie, Luca Malcovati, MD, Mette Skov Holm, Antonio Medina Almeida, Krzysztof Madry, Borhane Slama, Agnès Guerci-Bresler, MD, PhD, Laurence Sanhes, MD, Odile Beyne-Rauzy, Elisa Luño, MD, David Bowen, MD, PhD, Theo de Witte
Journal: Blood
Blood (2013) 122 (21): 2770.
https://doi.org/10.1182/blood.V122.21.2770.2770
Published: 2013